Release Date: 24/09/20 08:32 Summary: IHL Receives Ethics Approval for Phase 2 OSA Trial Price Sensitive: Yes Download Document 159.67KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market